| Literature DB >> 26956385 |
Diego Gomez-Arbelaez1,2,3, Paul Anthony Camacho4, Daniel Dylan Cohen5,6, Sandra Saavedra-Cortes7, Cristina Lopez-Lopez8, Patricio Lopez-Jaramillo9,10.
Abstract
BACKGROUND: The current study aims to evaluate the association between neck circumference (NC) and several cardio-metabolic risk factors, to compare it with well-established anthropometric indices, and to determine the cut-off point value of NC for predicting children at increased risk of metabolic syndrome, insulin resistance and low-grade systemic inflammation.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26956385 PMCID: PMC4782326 DOI: 10.1186/s12887-016-0566-1
Source DB: PubMed Journal: BMC Pediatr ISSN: 1471-2431 Impact factor: 2.125
Demographic, anthropometric and metabolic data
| Total ( | Girls ( | Boys ( | |
|---|---|---|---|
| Age (years)a | 11.52 ± 1.13 | 11.52 ± 1.10 | 11.51 ± 1.16 |
| SBP (mmHg)a | 114.51 ± 11.59 | 113.29 ± 11.72 | 115.58 ± 11.38b |
| DBP (mmHg)a | 73.78 ± 9.47 | 73.66 ± 8.97 | 73.86 ± 9.93 |
| Anthropometric measuresa | |||
| Weight (kg) | 40.08 ± 10.07 | 40.33 ± 9.77 | 39.86 ± 10.35 |
| Height (m) | 1.45 ± 0.09 | 1.45 ± 0.08 | 1.44 ± 0.09b |
| BMI (kg/m2) | 18.87 ± 3.61 | 18.81 ± 3.52 | 18.93 ± 3.68 |
| WC (cm) | 65.95 ± 9.73 | 64.86 ± 9.02 | 66.92 ± 10.24b |
| WHR | 0.84 ± 0.08 | 0.81 ± 0.06 | 0.86 ± 0.09b |
| WHtR | 0.45 ± 0.06 | 0.44 ± 0.06 | 0.46 ± 0.06b |
| NC (cm) | 29.93 ± 2.39 | 28.40 ± 2.06 | 29.41 ± 2.55b |
| %BF-BIA | 20.47 ± 7.50 | 22.71 ± 6.89 | 18.43 ± 7.46b |
| %BF-Skinfold | 25.47 ± 11.37 | 24.63 ± 9.10 | 26.23 ± 13.04b |
| Z-score BMI (kg/m2) | -0.0004 ± 0.98 | -0.0008 ± 0.98 | -5.45-7 ± 0.98 |
| Z-score WC (cm) | -0.038 ± 0.99 | 4.88-8 ± 0.99 | -0.073 ± 0.99b |
| Biochemical measurementsa | |||
| FPG (mg/dl) | 88.52 ± 12.56 | 87.87 ± 12.32 | 89.12 ± 12.76 |
| TC (mg/dl) | 159.23 ± 39.28 | 158.25 ± 39.04 | 160.13 ± 39.53 |
| HDL-C (mg/dl) | 75.34 ± 19.96 | 74.57 ± 19.82 | 76.04 ± 20.08 |
| TG (mg/dl) | 91.76 ± 52.37 | 94.07 ± 46.79 | 89.67 ± 56.97b |
| hs-CRP (mg/dl) | 0.89 ± 1.62 | 0.88 ± 1.52 | 0.89 ± 1.71 |
| Insulin (lU/ml) | 2.58 ± 2.61 | 2.91 ± 2.91 | 2.29 ± 2.26b |
| HOMA-IR | 0.57 ± 0.58 | 0.64 ± 0.66 | 0.50 ± 0.50b |
| Weight status ( | |||
| o Underweight | 29 (4.4) | 9 (2.9) | 20 (5.8) |
| o Normal weight | 479 (72.8) | 240 (77.2) | 239 (68.9) |
| o Overweight | 85 (12.9) | 42 (13.5) | 43 (12.4) |
| o Obese | 65 (9.8) | 20 (6.4) | 45 (12.9) |
| Tanner stage ( | |||
| o 1 | 368 (56.3) | 149 (47.8) | 219 (64.0)c |
| o 2 | 208 (31.8) | 110 (35.3) | 98 (28.7) |
| o 3 | 78 (11.9) | 53 (16.9) | 25 (7.3) |
SBP systolic blood pressure, DBP diastolic blood pressure, BMI body mass index, WC waist circumference, WHR waist-to-hip ratio, WHtR waist-to-height ratio, NC neck circumference, %BF-BIA body fat percentage – bioelectrical impedance analysis, %BF-Skinfold body fat percentage – skinfolds, FPG fasting plasma glucose, TC total cholesterol, HDL-C high-density lipoprotein cholesterol, TG triglycerides, hs-CRP high sensitivity C-reactive protein
aData are presented as mean ± standard deviation for continuous variables. bMann-Whitney test p < 0.05. cPearson’s chi-squared test (Chi2) p <0.05
ddata missing for 11 participants
edata missing for 15 participants
Fig. 1Prevalence of metabolic syndrome and its components, insulin resistance and low-grade systemic inflammation among study population. Data are presented as relative frequencies with 95 % confidence intervals represented by vertical bars. Significant differences between girls and boys (Pearson’s chi-squared test (Chi2)). FPG: fasting plasma glucose; HDL-C: high-density lipoprotein cholesterol; TG: triglycerides; SBP: systolic blood pressure; DBP: diastolic blood pressure; WC: waist circumference; hs-CRP: high sensitivity C-reactive protein
Correlations between cardiometabolic risk factors and anthropometric measurements according to gender
| Z-score BMI | Z-score WC | Waist to hip ratio | Waist to height ratio | |||||||||
| Total | Girls | Boys | Total | Girls | Boys | Total | Girls | Boys | Total | Girls | Boys | |
| FPG (mg/dl) | 0.08 | 0.10 | 0.06 | 0.10* | 0.13* | 0.08 | -0.04 | -0.08 | -0.07 | 0.02 | 0.01 | 0.02 |
| HDL-C (mg/dl) | -0.12* | -0.09 | -0.15* | -0.16** | -0.10 | -0.21** | 0.02 | 0.01 | -0.02 | -0.06 | -0.08 | -0.07 |
| TG (mg/dl) | 0.16** | 0.15* | 0.17* | 0.23** | 0.19* | 0.25** | 0.10* | 0.12* | 0.20** | 0.15** | 0.15* | 0.19** |
| SBP (mmHg) | 0.29** | 0.28** | 0.30** | 0.31** | 0.31** | 0.33** | 0.08* | 0.01 | 0.04 | 0.21** | 0.17* | 0.21** |
| DBP (mmHg) | 0.35** | 0.36** | 0.33** | 0.35** | 0.33** | 0.37** | 0.06 | -0.03 | 0.17* | 0.29** | 0.26** | 0.33** |
| hs-CRP (mg/dl) | 0.15* | 0.19* | 0.12* | 0.15** | 0.21** | 0.09 | 0.04 | 0.12* | 0.01 | 0.14** | 0.22** | 0.08 |
| Insulin (Ul/ml) | 0.27** | 0.28** | 0.27** | 0.29** | 0.23** | 0.33** | 0.06 | 0.06 | 0.23** | 0.24** | 0.21** | 0.34** |
| HOMA-IR | 0.27** | 0.27** | 0.26** | 0.29** | 0.24** | 0.33** | 0.05 | 0.03 | 0.21** | 0.24** | 0.20* | 0.33** |
| %BF – BIA | %BF - Skinfold | Neck Circumference | ||||||||||
| Total | Girls | Boys | Total | Girls | Boys | Total | Girls | Boys | ||||
| FPG (mg/dl) | 0.01 | 0.09 | -0.03 | 0.06 | 0.10 | 0.04 | 0.20** | 0.19** | 0.19** | |||
| HDL-C (mg/dl) | -0.09* | -0.12* | -0.02 | -0.12* | -0.11* | -0.13* | -0.19** | -0.12* | -0.29** | |||
| TG (mg/dl) | 0.18** | 0.13* | 0.17* | 0.15** | 0.09 | 0.19** | 0.11* | 0.10 | 0.18* | |||
| SBP (mg/dl) | 0.17** | 0.26** | 0.20** | 0.24** | 0.25** | 0.23** | 0.39** | 0.34** | 0.42** | |||
| DBP (mg/dl) | 0.33** | 0.39** | 0.32** | 0.35** | 0.41** | 0.30** | 0.29** | 0.29** | 0.31** | |||
| hs-CRP (mg/dl) | 0.11* | 0.18* | 0.05 | 0.16** | 0.18* | 0.15* | 0.15** | 0.17* | 0.15* | |||
| Insulin (Ul/ml) | 0.30** | 0.24** | 0.29** | 0.28** | 0.21** | 0.33** | 0.19** | 0.22** | 0.25** | |||
| HOMA-IR | 0.28** | 0.24** | 0.27** | 0.28** | 0.23** | 0.32** | 0.21** | 0.23** | 0.27** | |||
*Spearman’s correlation coefficient p < 0.05. **Spearman’s correlation coefficient p < 0.001
BMI body mass index, WC waist circumference, %BF-BIA body fat percentage – bioelectrical impedance analysis, %BF-Skinfold body fat percentage – skinfolds, FPG fasting plasma glucose, HDL-C high-density lipoprotein cholesterol, TG triglycerides, SBP systolic blood pressure, DBP diastolic blood pressure, hs-CRP high sensitivity C-reactive protein
Multiple linear regression analysis, using each cardiometabolic risk factor as the dependent variable
| Dependent variable | Independent factor | Coef. ± SE |
| Dependent variable | Independent factor | Coef. ± SE |
|
|---|---|---|---|---|---|---|---|
| FPG (mg/dl) | BMI (kg/m2) | 0.193 ± 0.149 | 0.194 | DBP (mmHg) | BMI (kg/m2) | 0.849 ± 0.106 | <0.001 |
| WC (cm) | 0.100 ± 0.056 | 0.075 | WC (cm) | 0.346 ± 0.039 | <0.001 | ||
| WHR | -12.777 ± 6.791 | 0.060 | WHR | 7.498 ± 5.024 | 0.136 | ||
| WHtR | 2.198 ± 8.620 | 0.799 | WHtR | 46.847 ± 6.094 | <0.001 | ||
| %BF-BIA | 0.063 ± 0.075 | 0.399 | %BF-BIA | 0.500 ± 0.051 | <0.001 | ||
| %BF-Skinfold | 0.039 ± 0.045 | 0.393 | %BF-Skinfold | 0.283 ± 0.031 | <0.001 | ||
| NC (cm) | 0.815 ± 0.244 | 0.001 | NC (cm) | 1.305 ± 0.173 | <0.001 | ||
| HDL-C (mg/dl) | BMI (kg/m2) | -0.279 ± 0.236 | 0.237 | hs-CRP (mg/dl) | BMI (kg/m2) | 0.132 ± 0.020 | <0.001 |
| WC (cm) | -0.237 ± 0.088 | 0.008 | WC (cm) | 0.043 ± 0.007 | <0.001 | ||
| WHR | -6.135 ± 10.745 | 0.568 | WHR | 2.459 ± 0.936 | 0.009 | ||
| WHtR | -21.145 ± 13.584 | 0.120 | WHtR | 7.225 ± 1.177 | <0.001 | ||
| %BF-BIA | -0.149 ± 0.116 | 0.203 | %BF-BIA | 0.061 ± 0.010 | <0.001 | ||
| %BF-Skinfold | -0.133 ± 0.072 | 0.067 | %BF-Skinfold | 0.037 ± 0.006 | <0.001 | ||
| NC (cm) | -1.333 ± 0.384 | 0.001 | NC (cm) | 0.133 ± 0.034 | <0.001 | ||
| TG (mg/dl) | BMI (kg/m2) | 2.149 ± 0.621 | 0.001 | Insulin (Ul/ml) | BMI (kg/m2) | 0.245 ± 0.031 | <0.001 |
| WC (cm) | 1.253 ± 0.229 | <0.001 | WC (cm) | 0.108 ± 0.011 | <0.001 | ||
| WHR | 104.268 ± 28.023 | <0.001 | WHR | 5.850 ± 1.448 | <0.001 | ||
| WHtR | 155.901 ± 35.351 | <0.001 | WHtR | 14.963 ± 1.785 | <0.001 | ||
| %BF-BIA | 1.260 ± 0.313 | <0.001 | %BF-BIA | 0.130 ± 0.015 | <0.001 | ||
| %BF-Skinfold | 0.754 ± 0.190 | <0.001 | %BF-Skinfold | 0.086 ± 0.009 | <0.001 | ||
| NC (cm) | 3.887 ± 1.014 | <0.001 | NC (cm) | 0.362 ± 0.051 | <0.001 | ||
| SBP (mmHg) | BMI (kg/m2) | 0.705 ± 0.129 | <0.001 | HOMA-IR | BMI (kg/m2) | 0.055 ± 0.007 | <0.001 |
| WC (cm) | 0.311 ± 0.048 | <0.001 | WC (cm) | 0.024 ± 0.002 | <0.001 | ||
| WHR | 7.001 ± 6.020 | 0.245 | WHR | 1.192 ± 0.330 | <0.001 | ||
| WHtR | 34.576 ± 7.503 | <0.001 | WHtR | 3.306 ± 0.407 | <0.001 | ||
| %BF-BIA | 0.362 ± 0.064 | <0.001 | %BF-BIA | 0.029 ± 0.003 | <0.001 | ||
| %BF-Skinfold | 0.206 ± 0.039 | <0.001 | %BF-Skinfold | 0.018 ± 0.002 | <0.001 | ||
| NC (cm) | 1.719 ± 0.205 | <0.001 | NC (cm) | 0.085 ± 0.011 | <0.001 |
After controlling for age, gender and Tanner stage
FPG fasting plasma glucose, HDL-C high-density lipoprotein cholesterol, TG triglycerides, SBP systolic blood pressure, DBP diastolic blood pressure, hs-CRP high sensitivity C-reactive protein, BMI body mass index, WC waist circumference, WHR waist-to-hip ratio, WHtR waist-to-height ratio, %BF-BIA body fat percentage – bioelectrical impedance analysis, %BF-Skinfold body fat percentage – skinfolds, NC neck circumference
Neck circumference cut-offs points to identify metabolic syndrome, low-grade systemic inflammation and insulin resistance in study sample according to gender
| Cutoffs (cm) | Sensitivity (%) | Specificity (%) | AUC (IC 95 %) | Youden’s index | |
|---|---|---|---|---|---|
| Metabolic Syndrome | |||||
| Girls | 28.5 | 87.50 | 53.61 | 0.73 (0.68 - 0.78) | 0.41 |
| Boys | 29 | 100 | 45.37 | 0.74 (0.68 - 0.78) | 0.45 |
| Low-grade systemic inflammation | |||||
| Girls | 29.3 | 42.02 | 69.15 | 0.55 (0.49 - 0.60) | 0.11 |
| Boys | 29.2 | 54.62 | 51.63 | 0.53 (0.47 - 0.58) | 0.06 |
| Insulin resistance | |||||
| Girls | 29 | 50.00 | 62.35 | 0.57 (0.51 - 0.62) | 0.12 |
| Boys | 30 | 52.54 | 61.19 | 0.54 (0.49 - 0.59) | 0.13 |
Receiver operating characteristic (ROC) analyzes. Youden’s index = Sensitivity + Specificity – 1
Advantages and limitations in pediatric population of anthropometrics measurements to identify metabolic alterations
| FPG | HDL-C | TG | SPB/DPB | hs-CRP | Insulin | HOMA-IR | |
|---|---|---|---|---|---|---|---|
| BMI | - | + | ++ | ++ | ++ | ++ | ++ |
| WC | + | + | ++ | ++ | ++ | ++ | ++ |
| WHR | - | - | ++ | + | + | + | + |
| WHtR | - | - | ++ | ++ | + | ++ | ++ |
| %BF-BIA | - | + | ++ | ++ | + | ++ | ++ |
| %BF-Skinfold | - | ++ | + | ++ | ++ | ++ | ++ |
| NC | ++ | ++ | + | ++ | ++ | ++ | ++ |
(-) Not correlation; (+) Correlation in girls or boys; (++) Correlation in both girls and boys
FPG fasting plasma glucose, HDL-C high-density lipoprotein cholesterol, TG triglycerides, SBP systolic blood pressure, DBP diastolic blood pressure, hs-CRP high sensitivity C-reactive protein, BMI body mass index, WC waist circumference, WHR waist-to-hip ratio, WHtR waist-to-height ratio, %BF-BIA body fat percentage – bioelectrical impedance analysis, %BF-Skinfold body fat percentage – skinfolds, NC neck circumference